RenovoRx's PanTheR Post-Marketing Registry Study Progresses with First Clinical Procedure and Addition of Two Participating Clinical Sites Biotech Investing
Rallybio Completes Dosing of First Cohort in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study Biotech Investing
Nuvectis Pharma Appoints Biotech Executive Juan Sanchez, MD, to the Board of Directors Biotech Investing
Respira Therapeutics Enters into Agreement with Gossamer Bio Granting Gossamer Option to Acquire Respira from Samsara BioCapital Pharmaceutical Investing
Clearmind Medicine's Convenes Inaugural Scientific Advisory Board Meeting to Advance Psychedelic-Derived Therapies Biotech Investing
Gossamer Bio Enters into Option Agreement to Acquire Respira Therapeutics and Its Lead Candidate, RT234, an Inhaled, On?Demand Vardenafil for Pulmonary Hypertension Pharmaceutical Investing
MiNK Therapeutics Dr. Jennifer Buell to Deliver Featured Plenary at 10th Annual CAR-TCR Summit in Boston, MA Biotech Investing
QULIPTA® Now Publicly Reimbursed in Quebec for Chronic Migraine and CGRP Class Review Published Pharmaceutical Investing
Covalon Presents Evidence-Backed Innovations Making a Difference for Critically Ill Children at APHON Biotech Investing
Bristol Myers Squibb Builds on Eliquis® Direct-to-Patient Program, Announces New BMS Patient Connect Platform Offering Sotyktu® Pharmaceutical Investing
